HomeLPGO • STO
add
Lipigon Pharmaceuticals AB
Previous close
kr 0.16
Day range
kr 0.16 - kr 0.17
Year range
kr 0.066 - kr 0.28
Market cap
96.04M SEK
Avg Volume
3.15M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | -1.00K | -100.01% |
Operating expense | 2.52M | 32.84% |
Net income | -8.70M | -1,995.42% |
Net profit margin | 869.60K | 18,781,957.45% |
Earnings per share | — | — |
EBITDA | -8.47M | -1,607.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.99M | 28.28% |
Total assets | 26.57M | -12.34% |
Total liabilities | 4.11M | -18.79% |
Total equity | 22.46M | — |
Shares outstanding | 605.93M | — |
Price to book | 3.99 | — |
Return on assets | -67.38% | — |
Return on capital | -82.09% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -8.70M | -1,995.42% |
Cash from operations | -11.35M | -33.47% |
Cash from investing | — | — |
Cash from financing | 32.58M | 667.76% |
Net change in cash | 21.22M | 568.91% |
Free cash flow | 22.57M | 359.36% |
About
Founded
2010
Website
Employees
7
